Companhia de Saneamento de Minas Gerais (CSMG3) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Net revenue for Q3 2024 reached R$1.78 billion, up 9.6% year-over-year, driven by tariff adjustments and higher measured volumes in water and sewage.
Adjusted EBITDA rose 13.6% to R$725.7 million, with margin improving to 40.5% from 38.5% in Q3 2023.
Adjusted net income was R$368.3 million, a 9.3% increase over Q3 2023, excluding prior year non-recurring labor reversals.
Investments in 9M24 totaled R$1.56 billion, up 30.7% year-over-year, supporting expansion and modernization.
Regular and extraordinary dividends declared in 2024 totaled R$752.2 million.
Financial highlights
Costs and expenses for Q3 2024 totaled R$1.21 billion, up 6% year-over-year, with manageable costs up 6.8% and non-manageable costs up 6%.
Net financial result was a negative R$50.9 million, impacted by higher foreign exchange expenses and increased gross debt.
Delinquency rate declined to 2.97%, the lowest in 7 years.
CapEx for the first nine months was R$1.56 billion, with 82% of the annual forecast already invested.
Other operational revenues fell 51.8% year-over-year, while other operational expenses surged due to absence of prior year reversals.
Outlook and guidance
Multi-year investment program (2025–2028) targets R$1.97 billion annually to expand water and sewage systems and meet regulatory goals.
Ongoing tariff review process to set new rates effective January 2026.
Água dos Vales PPP project aims to universalize sanitation in 92 municipalities, with public consultation ongoing.
Ongoing negotiations with municipalities to extend and rebalance contracts, aiming to mitigate regulatory risks and ensure revenue stability.
Focus on regulatory enhancements and asset base expansion to support future tariff cycles and shareholder returns.
Latest events from Companhia de Saneamento de Minas Gerais
- Net income up 30.4% and EBITDA margin at 41.4%, with record investments and higher dividends.CSMG3
Q2 202416 Jul 2026 - Revenue up 6.8% to R$6.97B, EBITDA margin 39.7%, net income R$1.32B, record investments.CSMG3
Q4 202413 Jul 2026 - Net income fell 14.1% as investments and leverage rose, despite revenue growth and concession renewal.CSMG3
Q1 20269 Jul 2026 - Net income reached BRL 1.42B, EBITDA margin 39.8%, and CapEx hit BRL 2.9B in 2025.CSMG3
Q4 20256 Jul 2026 - CapEx rose 26%, EBITDA margin held near 40%, and privatization and investments advanced.CSMG3
Q3 20256 Jul 2026 - Revenue up, profit down; investments and leverage rise amid regulatory changes.CSMG3
Q2 20256 Jul 2026 - Net income up 21.9% and investments up 45.9% year-over-year, with record-low delinquency.CSMG3
Q1 20256 Jul 2026